Prestige Consumer Healthcare (PBH) Cash from Financing Activities (2010 - 2025)

Prestige Consumer Healthcare's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at -$6.7 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 87.5% year-over-year to -$6.7 million; the TTM figure through Dec 2025 stood at -$129.5 million (up 45.84% YoY), while the FY2025 annual figure was -$182.1 million, up 24.45% from the prior year.
• Cash from Financing Activities was -$6.7 million for Q4 2025 at Prestige Consumer Healthcare, up from -$74.9 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $63.6 million in Q2 2021 to a low of -$83.7 million in Q1 2021.
• Historically, Cash from Financing Activities has averaged -$40.9 million across 5 years, with a median of -$53.7 million in 2023.
• Biggest YoY gain for Cash from Financing Activities was 167.11% in 2021; the steepest drop was 647.88% in 2021.
• A 5-year view of Cash from Financing Activities shows it stood at -$67.6 million in 2021, then soared by 85.18% to -$10.0 million in 2022, then plunged by 547.07% to -$64.8 million in 2023, then climbed by 16.93% to -$53.9 million in 2024, then jumped by 87.5% to -$6.7 million in 2025.
• The last three Cash from Financing Activities figures came in at -$6.7 million (Q4 2025), -$74.9 million (Q3 2025), and -$36.3 million (Q2 2025), per Business Quant data.